Pacific Biosciences of California (MEX:PACB) Other Current Payables: MXN0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:PACB Pacific Biosciences of California Inc MEX:PACB
55 GF Score
Price MXN27.50
GF Value MXN35.24
! 6 Warning Signs
View Full Analysis

What is Pacific Biosciences of California Other Current Payables?

Pacific Biosciences of California MEX:PACB 55 Other Current Payables is MXN0 Mil as of Jun. 2026. GuruFocus rates MEX:PACB with a GF Score™ of 55/100 and a GF Value™ of MXN35.24. The stock has 6 warning signs investors should review.

Pacific Biosciences of California's Other Current Payables for the quarter that ended in Jun. 2026 was MXN0 Mil.

Pacific Biosciences of California Other Current Payables Related Terms

Pacific Biosciences of California Other Current Payables Historical Data

* Premium members only.

The historical data trend for Pacific Biosciences of California's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pacific Biosciences of California Other Current Payables Chart

Pacific Biosciences of California Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Pacific Biosciences of California Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MEX:PACB
55GF Score
Pacific Biosciences of California Inc MEX:PACB
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pacific Biosciences of California Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of MXN0 Mil mean?
Pacific Biosciences of California (MEX:PACB) has a Other Current Payables of MXN0 Mil as of Jun. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Pacific Biosciences of California and its competitors.
Is Pacific Biosciences of California's Other Current Payables too high?
Pacific Biosciences of California's current Other Current Payables is MXN0 Mil. Overall, Pacific Biosciences of California has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does Pacific Biosciences of California's Other Current Payables compare to DCTH and CLPT?
Pacific Biosciences of California's Other Current Payables of MXN0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Medical Devices & Instruments company?
A good Other Current Payables depends on the Medical Devices & Instruments industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Pacific Biosciences of California and its competitors. Pacific Biosciences of California's current Other Current Payables is MXN0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pacific Biosciences of California stock overvalued right now?
Pacific Biosciences of California (MEX:PACB) has a current Other Current Payables of MXN0 Mil. The stock's GF Value™ is MXN35.24, compared to a current price of MXN27.50 — trading 22% below its estimated fair value. The current Other Current Payables is MXN0 Mil. Pacific Biosciences of California's overall GF Score™ is 55/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Pacific Biosciences of California (MEX:PACB), the current Other Current Payables is MXN0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pacific Biosciences of California (MEX:PACB) Overvalued in 2026?

Based on GuruFocus' analysis, Pacific Biosciences of California stock appears to be undervalued. The current stock price of MXN27.50 is trading 22% below its estimated GF Value™ of MXN35.24.

Key valuation signals for MEX:PACB:

  • Other Current Payables: MXN0 Mil
  • GF Value™: MXN35.24 vs. price of MXN27.50 (22% below fair value)
  • GF Score™: 55/100 with 6 warning signs

No single metric tells the full story. See the MEX:PACB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pacific Biosciences of California Business Description

Other Exchanges PACB:USAP09:Germany
Address 1305 O’Brien Drive, Menlo Park, CA, USA, 94025
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
55GF Score

Get the complete analysis for MEX:PACB

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN27.50
Price
MXN35.24
GF Value